Acute cerebrovascular accidents in patients with new coronavirus infection COVID-19
N. A. Shamalov,
L. V. Klimov,
M. A. Soldatov,
T. V. Kiseleva,
V. N. Shamalova,
N. A. Marskaya,
O. V. Lyang https://doi.org/10.14412/2074-2711-2024-1-82-86
Abstract
The incidence of neurological complications in COVID-19 can reach 8–10% of all cases of new coronavirus infection; acute cerebrovascular accidents (ACA) dominate in their structure, which cause significant social and economic costs due to the high mortality and disability rates in this group of patients. The main pathophysiological mechanism leading to the development of ischemic cerebrovascular accidents (ischemic stroke, transient ischemic attack) is the phenomenon of hypercoagulation, which, together with the systemic inflammatory response to the viral infection, leads to the formation of macro- and microthrombi and the development of ischemic disorders of cerebral circulation. The ischemic stroke associated with COVID-19 is characterized by the onset at a younger age, the predominance of cryptogenic and cardioembolic pathogenetic variants, a more frequent occlusion of large cerebral vessels and thus a more pronounced clinical picture of the disease. The reserves for reducing mortality and disability in patients with cerebrovascular disease, especially stroke, during the spread of COVID-19 lie both in the prevention, treatment and rehabilitation of COVID-19 in patients at high risk of developing cardiovascular diseases and in ensuring specialized medical care for this category of patients.
About the Authors
N. A. Shamalov
Federal Center of Brain and Neurotechnologies, Federal Biomedical Agency
Russian Federation
Competing Interests:
Russian Federation
1, Ostrovityanova St., Build. 10, Moscow 117997
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
L. V. Klimov
Federal Center of Brain and Neurotechnologies, Federal Biomedical Agency
Russian Federation
Competing Interests:
Russian Federation
1, Ostrovityanova St., Build. 10, Moscow 117997
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
M. A. Soldatov
Federal Center of Brain and Neurotechnologies, Federal Biomedical Agency
Russian Federation
Competing Interests:
Russian Federation
1, Ostrovityanova St., Build. 10, Moscow 117997
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
T. V. Kiseleva
Federal Center of Brain and Neurotechnologies, Federal Biomedical Agency
Russian Federation
Competing Interests:
Russian Federation
1, Ostrovityanova St., Build. 10, Moscow 117997
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
V. N. Shamalova
Federal Center of Brain and Neurotechnologies, Federal Biomedical Agency
Russian Federation
Competing Interests:
Russian Federation
1, Ostrovityanova St., Build. 10, Moscow 117997
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
N. A. Marskaya
Federal Center of Brain and Neurotechnologies, Federal Biomedical Agency
Russian Federation
Competing Interests:
Russian Federation
1, Ostrovityanova St., Build. 10, Moscow 117997
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
O. V. Lyang
Federal Center of Brain and Neurotechnologies, Federal Biomedical Agency
Russian Federation
Competing Interests:
Russian Federation
1, Ostrovityanova St., Build. 10, Moscow 117997
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
References
1. World Health Organization. Available at: https://www.who.int/ru/dg/speeches/detail/who-director-general-s-opening-remarks-at-themedia-briefing-on-covid-19---11-March2020.
2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30.
3. Horby P, Lim WS, Emberson J, et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report., RECOVERY Collaborative Group. medRxiv. 2020.06.22.20137273. doi: 10.1101/2020.06.22.20137273
4. Rifino N, Censori B, Agazzi E, et al. Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy. J Neurol. 2021 Jul;268(7):2331-8. doi: 10.1007/s00415-020-10251-5. Epub 2020 Oct 7.
5. Kumar M, Thakur AK. Neurological manifestations and comorbidity associated with COVID-19: an overview. Neurol Sci. 2020 Dec;41(12):3409-18. doi: 10.1007/s10072-020-04823-6. Epub 2020 Oct 14.
6. Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020 Sep;19(9):767-83. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.
7. AHA/ASA Stroke Council Leadership. Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic: On Behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2020 Jun;51(6):1910-2. doi: 10.1161/STROKEAHA.120.030023. Epub 2020 Apr 1.
8. Wira CR, Goyal M, Southerland AM, et al; AHA/ASA Stroke Council Science Subcommittees: Emergency Neurovascular Care (ENCC), Telestroke and the Neurovascular Intervention Committees; and on behalf of the Stroke Nursing Science Subcommittee of the AHA/ASA Cardiovascular and Stroke Nursing Council. Pandemic Guidance for Stroke Centers Aiding COVID-19 Treatment Teams. Stroke. 2020 Aug;51(8):2587-92. doi: 10.1161/STROKEAHA.120.030749. Epub 2020 Jun 23.
9. Nguyen TN, Abdalkader M, Jovin TG, et al. Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology. Stroke. 2020 Jun;51(6):1896-901. doi: 10.1161/STROKEAHA.120.030100. Epub 2020 Apr 29.
10. Qureshi AI, Abd-Allah F, Al-Senani F, et al. Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel. Int J Stroke. 2020 Jul;15(5):540-54. doi: 10.1177/1747493020923234. Epub 2020 May 3. Erratum in: Int J Stroke. 2020 Jun 22:1747493020935396.
11. Aguiar de Sousa D, van der Worp HB, Caso V, et al; European Stroke Organisation. Maintaining stroke care in Europe during the COVID-19 pandemic: Results from an international survey of stroke professionals and practice recommendations from the European Stroke Organisation. Eur Stroke J. 2020 Sep;5(3):230-6. doi: 10.1177/2396987320933746. Epub 2020 Jun 10.
12. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844-7. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
13. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May;17(5):259-60. doi: 10.1038/s41569-020-0360-5
14. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013 Jan;13(1):34-45. doi: 10.1038/nri3345. Epub 2012 Dec 7.
15. Esenwa C, Cheng NT, Luna J, et al. Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke. Stroke. 2021 Nov;52(11):e706-e709. doi: 10.1161/STROKEAHA.121.035045. Epub 2021 Aug 25.
16. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
17. Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells. 2020 Jul 9;9(7):1652. doi: 10.3390/cells9071652
18. Siegler JE, Heslin ME, Thau L, et al. Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center. J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104953. doi: 10.1016/j.jstrokecerebrovasdis.2020.104953. Epub 2020 May 14.
19. Srivastava PK, Zhang S, Xian Y, et al. Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The GuidelinesStroke. Stroke. 2021 Oct;52(10):3225-32. doi: 10.1161/STROKEAHA.120.034414. Epub 2021 Jul 1.
20. Yaghi S, Ishida K, Torres J, et al. SARSCoV-2 and Stroke in a New York Healthcare System. Stroke. 2020 Jul;51(7):2002-11. doi: 10.1161/STROKEAHA.120.030335. Epub 2020 May 20. Erratum in: Stroke. 2020 Aug;51(8):e179.
21. Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2021 Feb;16(2):137-49. doi: 10.1177/1747493020972922. Epub 2020 Nov 11.
22. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020 May 14;382(20):e60. doi: 10.1056/NEJMc2009787. Epub 2020 Apr 28.
23. Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020 May 1;70(9):311-22. doi: 10.33588/rn.7009.2020179
24. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020 Aug;296(2):E119-E120. doi: 10.1148/radiol.2020201187. Epub 2020 Mar 31.
25. Franceschi AM, Ahmed O, Giliberto L, Castillo M. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection. AJNR Am J Neuroradiol. 2020 Jul;41(7):1173-6. doi: 10.3174/ajnr.A6595. Epub 2020 May 21.
26. Muhammad S, Petridis A, Cornelius JF, HКnggi D. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19. Brain Behav Immun. 2020 Jul;87:150-1. doi: 10.1016/j.bbi.2020.05.015. Epub 2020 May 5.
27. Valderrama EV, Humbert K, Lord A, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke. Stroke. 2020 Jul;51(7):e124-e127. doi: 10.1161/STROKEAHA.120.030153. Epub 2020 May 12.
28. Temporary guidelines “Medical rehabilitation for new coronavirus infection (COVID-19). Version 3 (11/01/2022)" (approved by the Russian Ministry of Health).8. Neurological disorders and features of medical rehabilitation. Available at: https://www.consultant.ru/document/cons_doc_LAW_358669/8dda8df191569ec5e1a83da4ada25e7d0f29aa19/ (In Russ.).
29. Order of the Ministry of Health of Russia dated July 31, 2020 N 788n (as amended on November 7, 2022) “On approval of the Procedure for organizing medical rehabilitation of adults” (Registered with the Ministry of Justice of Russia on September 25, 2020 N 60039). Available at: https://www.consultant.ru/document/cons_doc_LAW_363102/251914c20e9de78b3ee8b2d5e0bf9dc53015020e/#dst100011 (In Russ.).
Review
For citations:
Shamalov NA, Klimov LV, Soldatov MA, Kiseleva TV, Shamalova VN, Marskaya NA, Lyang OV. Acute cerebrovascular accidents in patients with new coronavirus infection COVID-19. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(1):82-86. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1-82-86
Views: 300
Email this article 